Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Evelyn DeSantis
Evelyn R. Hermes-DeSantis, PharmD, BCPS, is the Director for Research and Publications for phactMI and Professor Emerita at the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey. She is dedicated to advancing and elevating the practice of medical information.
phactMI is a non-profit association representing medical information leadership of 30+ pharma companies. phactMI is an industry-wide consortium that focuses on increasing the awareness, credibility, and access to medical information. At phactMI, Evelyn has overseen and conducted numerous projects that have resulted in presentations and publications; precepted and mentored fellows; and has provided continuing education programs focused in medical information.
Prior to joining phactMI, Evelyn was a Clinical Professor at the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey and Director of Drug Information Services at Robert Wood Johnson University Hospital. In her role she was dedicated to training student pharmacists, residents, and fellows in medical information skills including medical literature evaluation and application. Her research focused in the area of provision of drug information services within in institutions, the relationship between hospital and industrial pharmacy practice, and education of pharmacists. She also has expertise in research study procedure design. She worked with the Rutgers Industry Pharmacy Fellowship program and mentored numerous fellows on their research project over the years.
Evelyn received both a bachelor’s degree (BS) in Pharmacy and a doctorate in pharmacy (PharmD) from Rutgers, The State University of New Jersey. She then completed a Drug Information specialty residency at the Medical College of Virginia Hospital in Richmond, Virginia prior to working at the University of Utah Hospital Drug Information Service for a few years.–
John Pracyk
John Pracyk is an executive medical leader with deep expertise in the safe and effective design, development, and commercialization of medical devices. Clinically trained as a Neurological Surgeon he possesses an uncommon blend of business and medical expertise and is a passionate proponent of value-based care and outcomes-driven, evidence-based practices. Dr. Pracyk is a recognized thought leader and program architect in the development of collaborative healthcare delivery platforms with a proven track record of multidisciplinary program buildouts and care redesign successes. A servant leader who motivates high-performing teams to outpace innovation timelines, exceed expectations, and fuel organizational transformation.
Prior to joining Olympus, Dr. Pracyk held multiple leadership roles of increasing responsibility with DePuy Synthes-Spine, Johnson & Johnson Medical Devices. He began his MedTech career in 2016 as Franchise Medical Director where he fostered meaningful innovation to drive safety and value for patients worldwide. There he delivered deep medical and scientific insights to the R&D and commercial teams for product ideation and development, including conceptual, hands-on evaluation, and clinical research perspectives.
In 2017, Dr. Pracyk was tapped to be medically responsible for J&J’s Global Spine Platform as the Franchise Medical Leader leveraging integrated procedural solutions to drive innovation and answer unmet clinical needs. He forged relationships with internal and external stakeholders, including Key Opinion Leaders, practicing surgeons, global regulatory agencies, professional societies, and executive leadership teams from hospitals, health systems, and integrated delivery networks.
In 2018, Dr. Pracyk was appointed Integrated Leader of Preclinical Research, Clinical Research, and Medical Affairs (PCM), a newly integrated scientific platform for Spine. The PCM concept incorporates product development with preclinical and clinical research outcomes and unifies them within the context of Medical Affairs to substantiate safety, performance, and value. Their objective is to ensure that all platform decisions are medically informed, surgically literate, clinically relevant, and financially sustainable. His PCM team’s accomplishments were spotlighted in J&J’s Meet the Innovator series as they got out in front of all goals, condensed timetables to move ahead, and completed the clinical post market clinical follow up plans for the new European Medical Device Regulation a full year ahead of schedule.
Outside of Olympus, Dr. Pracyk is becoming a leading voice in the Medical Affairs Professional Society (MAPS) where he was elected President of the Americas Region, Treasurer of the Executive Committee, and Board Director. MAPS amplifies the individual voices of over 6100 medical professionals that serve patients from within 200+ medical device and pharmaceutical manufacturers. By contextualizing the real-world clinical needs of patients, providers, and policy makers MAPS succinctly translates science into value to deliver a strategically critical scientific perspective in today’s ever-changing global healthcare landscape.
Dr. Pracyk obtained his BS, MD and PhD degrees through the Early Identification and the Medical Scientist Training Programs at Duke University. He was competitively awarded research fellowships at Cambridge University and the National Institutes of Health. He received his Neurological Surgery training at Duke University & The George Washington University and then completed a clinical spine fellowship at the University of Iowa. In 2015, he obtained a healthcare focused MBA at the Haslam College of Business of The University of Tennessee. Dr. Pracyk is a Fellow of the American Association of Neurological Surgeons and the American College of Surgeons, as well as a Diplomate of the American Board of Neurological Surgery. He maintains active memberships in the Medical Affairs Professional Society, American Association of Neurological Surgeons, Congress of Neurological Surgeons, North American Spine Society, AO Spine, Phi Kappa Phi, and the American College of Healthcare Executives.
Ivan Desviat
Ivan Desviat, MBA, CHCP is Director Medical Education Excellence for AbbVie biotech overseeing company led Medical Education strategic planning, implementation approach, and program impact measures for Medical Affairs across all company’s Therapeutic Areas at Global HQ and affiliates. He brings more than 20 years of documented success across a variety of Affiliate, EU Regional, US and Global assignments in Medical Affairs organization, Commercial teams and Continuous Performance roles.
Ivan is recognized for enhancing Medical Affairs internal capabilities such as scientific platforms, KOL engagement, insights, internal training and delivering educational engagement strategies with innovative programs in different local, regional, and global roles.
He has author several congresses oral, and posters related to medical education research and was granted in 2017 the prestigious GAME Medical Education international award for a PI program in collaboration with the health agency in Spain.
He recently accepted the role of Co-Chair of the MAPS External Education Focus Area Working Group. In this effort he will be working to enhance the value of Medical Affairs education within the industry while providing visibility to new approaches and solutions recently created in response to the changing landscape.
Ivan received the bachelor’s degree in industrial chemistry (M.Sc.) from the Universidad Complutense of Madrid (Spain), and was recipient of an Erasmus study grant to complete the Chemical Engineering degree (ChE) from the Ecole européenne de Chimie, Polymères et Materieu at Strasburg (France). He completed his MBA at Instituto de Empresa (IE), and holds a six sigma black belt and CHCP certification.
Arron Mungul
Arron joined Bristol-Myers Squibb (BMS) in 2015 in the Global Medical Affairs team, where he was the Market Interface Lead, supporting the implementation of local strategy and launches across oncology. Currently, Arron is part of the Medical Capabilities group, leading an international team responsible for the medical content supporting the execution of local medical affairs plans in Europe and Canada for the entire BMS portfolio.
Prior to BMS, Arron was a Senior Scientific Director in Global Medical Affairs at GSK Oncology and Novartis Oncology, responsible for scientific strategy and communications across several brands. He has also worked in medical communications agencies in London and Switzerland.
Arron received his degree in Biochemistry from Imperial College, London, and his PhD from the Imperial Cancer Research Fund/Cancer Research UK for his work in breast cancer.
